These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12692749

  • 1. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL.
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
    [Abstract] [Full Text] [Related]

  • 2. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 3. Effects of ACE inhibition on the course of nephropathy in type I diabetes mellitus.
    Meinders AE, Hes R, de Leeuw PW.
    Neth J Med; 1992 Jun; 40(5-6):217-20. PubMed ID: 1436257
    [Abstract] [Full Text] [Related]

  • 4. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T, Khanna A, Kimball K, Wesson DE.
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [Abstract] [Full Text] [Related]

  • 5. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS.
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [Abstract] [Full Text] [Related]

  • 6. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 7. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE.
    Clin Invest Med; 1991 Dec 15; 14(6):642-51. PubMed ID: 1665407
    [Abstract] [Full Text] [Related]

  • 8. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar 15; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC.
    Diabetes Obes Metab; 2006 May 15; 8(3):342-7. PubMed ID: 16634995
    [Abstract] [Full Text] [Related]

  • 10. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar 15; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 11. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.
    Poulsen PL, Ebbehøj E, Mogensen CE.
    J Intern Med; 2001 May 15; 249(5):433-40. PubMed ID: 11350567
    [Abstract] [Full Text] [Related]

  • 12. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes?
    Danne T, Kordonouri O.
    J Pediatr Endocrinol Metab; 1998 Apr 15; 11 Suppl 2():347-63. PubMed ID: 9642665
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB, Britton ML.
    Pharmacotherapy; 2005 Nov 15; 25(11):1602-20. PubMed ID: 16232022
    [Abstract] [Full Text] [Related]

  • 14. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G, Giustina A, Cravarezza P, Caldonazzo A, Agabiti-Rosei E, Giustina G.
    J Hum Hypertens; 1991 Jun 15; 5(3):167-73. PubMed ID: 1920340
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.
    Sano T, Hotta N, Kawamura T, Matsumae H, Chaya S, Sasaki H, Nakayama M, Hara T, Matsuo S, Sakamoto N.
    Diabet Med; 1996 Feb 15; 13(2):120-4. PubMed ID: 8641115
    [Abstract] [Full Text] [Related]

  • 16. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE.
    J Hypertens Suppl; 2003 Mar 15; 21(1):S25-30. PubMed ID: 12769164
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G, Chaturvedi N.
    Kidney Int Suppl; 1997 Dec 15; 63():S32-5. PubMed ID: 9407417
    [Abstract] [Full Text] [Related]

  • 18. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
    Schwarz C, Oberbauer R.
    Wien Klin Wochenschr; 2000 Nov 10; 112(21):907-11. PubMed ID: 11144004
    [Abstract] [Full Text] [Related]

  • 19. High normo- or low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus.
    Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE.
    Kidney Int Suppl; 1997 Dec 10; 63():S15-8. PubMed ID: 9407413
    [Abstract] [Full Text] [Related]

  • 20. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH.
    J Diabetes Complications; 1996 Dec 10; 10(3):133-5. PubMed ID: 8807457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.